Table 3. Comparison of TTNT at 4 years... | American Society of Hematology

Table 3.

Comparison of TTNT at 4 years according to risk factors at diagnosis

Risk factors	n	TTNT at 4 years, %	P value^a
All	313	61
Age, y			.008
<65	143	70
≥65	170	53
Ibrutinib use			<.0001
First or second line	104	68
Third or further lines	209	48
IGHV status			.14
Mutated	31	41
Unmutated	71	70
*Del(17p) and/or TP53* mutation**			.002
Absent	152	68
Present	42	43

Risk factors	n	TTNT at 4 years, %	P value^a
All	313	61
Age, y			.008
<65	143	70
≥65	170	53
Ibrutinib use			<.0001
First or second line	104	68
Third or further lines	209	48
IGHV status			.14
Mutated	31	41
Unmutated	71	70
*Del(17p) and/or TP53* mutation**			.002
Absent	152	68
Present	42	43

^a

P value ≤ .05 is boldfaced.